These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29110282)

  • 21. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.
    Docherty JR
    Eur J Pharmacol; 2012 Mar; 679(1-3):90-4. PubMed ID: 22290390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
    Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
    Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine.
    Liu YL; Heal DJ; Stock MJ
    Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1245-53. PubMed ID: 12187403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
    Cleary L; Vandeputte C; Docherty JR
    Br J Pharmacol; 2003 Mar; 138(6):1069-76. PubMed ID: 12684262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
    Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
    Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressor nerve responses in the pithed rat, previously identified as α2-adrenoceptor mediated, may be α1D-adrenoceptor mediated.
    Docherty JR
    Eur J Pharmacol; 2011 May; 658(2-3):182-6. PubMed ID: 21376031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
    Jin J; Wang XB; Kong LY
    Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biofunctional studies of new 2-methoxyphenylpiperazine xanthone derivatives with α₁-adrenolytic properties.
    Rapacz A; Sapa J; Nowiński L; Mogilski S; Pytka K; Filipek B; Siwek A; Szkaradek N; Marona H
    Pharmacol Rep; 2015 Apr; 67(2):267-74. PubMed ID: 25712649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.
    Martínez-Salas SG; Campos-Peralta JM; Pares-Hipolito J; Gallardo-Ortíz IA; Ibarra M; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2007 Jul; 27(3):137-42. PubMed ID: 17584443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.
    Handzlik J; Pertz HH; Görnemann T; Jähnichen S; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6152-6. PubMed ID: 20813529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor.
    Silva RO; de Oliveira AS; Nunes Lemes LF; de Camargo Nascente L; Coelho do Nascimento Nogueira P; Silveira ER; Brand GD; Vistoli G; Cilia A; Poggesi E; Buccioni M; Marucci G; Bolognesi ML; Romeiro LAS
    Eur J Med Chem; 2016 Oct; 122():601-610. PubMed ID: 27448917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.
    Axel AM; Mikkelsen JD; Hansen HH
    Neuropsychopharmacology; 2010 Jun; 35(7):1464-76. PubMed ID: 20200509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific role of α2A - and α2B -, but not α2C -, adrenoceptor subtypes in the inhibition of the vasopressor sympathetic out-flow in diabetic pithed rats.
    Altamirano-Espinoza AH; Manrique-Maldonado G; Marichal-Cancino BA; Villalón CM
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):31-8. PubMed ID: 25407049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chiral analogues of (+)-cyclazosin as potent α
    Sagratini G; Buccioni M; Marucci G; Poggesi E; Skorski M; Costanzi S; Giardinà D
    Bioorg Med Chem; 2018 Jul; 26(12):3502-3513. PubMed ID: 29784274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
    Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
    Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.